Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Journal of Clinical and Experimental Neuropsychology|December 1, 1995
University of Southern California Repeatable Episodic Memory TestE S Parker, E M Eaton, S C Whipple, et al.Journal of the American Geriatrics Society|April 1, 1984
Peripheral catecholamine enzyme function and cognitive impairment of elderly schizophrenics and controlsT P Bridge, B H Phelps, N R Cutler, et al.Schizophrenia Bulletin|January 1, 1980
Monoamine oxidase in schizophrenia: an overviewR J Wyatt, S G Potkin, T P Bridge, et al.Journal of Gerontology|January 1, 1985
Platelet monoamine oxidase activity: demographic characteristics contribute to enzyme activity variabilityT P Bridge, B J Soldo, B H Phelps, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 18, 1999
Selegiline effects on cocaine-induced changes in medial temporal lobe metabolism and subjective ratings of euphoriaG Bartzokis, M Beckson, T Newton, et al.Psychiatry Research|October 1, 1979
Some kinetic parameters of platelet monoamine oxidase in chronic schizophreniaR D Kobes, S G Potkin, C D Wise, et al.Psychiatry Research|February 1, 1984
Schizophrenic outcome in late life: symptom state and platelet monoamine oxidase activityT P Bridge, D V Jeste, C D Wise, et al.The American Journal of Drug and Alcohol Abuse|November 21, 1997
Treatment of early AIDS dementia in intravenous drug users: high versus low dose peptide TT R Kosten, M I Rosen, T L McMahon, et al.Psychopharmacology Bulletin|January 1, 1991
Results of extended peptide T administration in AIDS and ARC patientsT P Bridge, P N Heseltine, E S Parker, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1991
Pharmacokinetics of peptide T in patients with acquired immunodeficiency syndrome (AIDS)M R Ruff, C Smith, T Kingan, et al.Pageof 3